Advertisement
Screener

INTENSITY THERAPEUTICS, INC. (INTS) Expense Breakdown

INTENSITY THERAPEUTICS, INC. Expense Breakdown

No Expense Breakdown for INTS on this site yet.

  • 2026-06-30: Reportable $1.25M.
  • 2025-06-30: Reportable $1.16M.

Source checked: the stored Expense Breakdown page for INTS.

Expenses by product

General and Administrative Expense: each quarter (3 month)

Quarter endReportable
2026-06-30$1.25M
2025-06-30$1.16M

Other General And Administrative Expense: each quarter (3 month)

Quarter endReportable
2026-06-30$225.00K
2025-06-30$106.00K

Research and development: each quarter (3 month)

Quarter endReportable
2026-06-30$1.83M
2025-06-30$1.54M

Research And Development Expense Salaries And Benefits: each quarter (3 month)

Quarter endReportable
2026-06-30$150.00K
2025-06-30$263.00K

Share-based Payment Arrangement, Expense: each quarter (3 month)

Quarter endReportable
2026-06-30$237.00K
2025-06-30$381.00K

Similar stocks

Stock NameCountryMarket CapPE Ratio
BRAINSTORM CELL THERAPEUTICS INC. (BCLI)United States$0.013B-1.05
Pluri Inc. (PLUR)$0.014B
IN8BIO, INC. (INAB)United States$0.012B-0.76
Senti Biosciences Holdings, Inc. (SNTI)United States$0.011B-0.70
Passage BIO, Inc. (PASG)United States$0.015B-0.43
DYADIC INTERNATIONAL INC (DYAI)United States$0.016B
BioCardia, Inc. (BCDA)United States$0.016B
TScan Therapeutics, Inc. (TCRX)United States$0.008B-1.23
CERO THERAPEUTICS HOLDINGS, INC. (CERO)United States$0.007B
Jasper Therapeutics, Inc. (JSPR)United States$0.020B-0.37